National Institute on Drug Abuse; Notice of Closed Meetings, 11552 [2010-5171]
Download as PDF
11552
Federal Register / Vol. 75, No. 47 / Thursday, March 11, 2010 / Notices
the staff of the Institute and discussions
concerning Institute programs.
Place: Melrose Hotel, 2430 Pennsylvania
Ave., NW., Washington, DC 20037.
Contact Person: Andrew P. Mariani, PhD,
Executive Secretary, National Advisory Eye
Council, Division of Extramural Research,
National Eye Institute, National Institutes of
Health, Bethesda, MD 20892, (301) 451–2020,
apm@nei.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
www.nei.nih.gov, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.867, Vision Research,
National Institutes of Health, HHS)
Dated: March 4, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–5175 Filed 3–10–10; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meetings
jlentini on DSKJ8SOYB1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal in formation concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of person al privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel Clinical
Coordinating Support for NIDA Center for
Clinical Trials Network (CCTN) (2221).
Date: April 6, 2010.
Time: 9 a.m. to 2 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Courtyard by Marriott Rockville,
2500 Research Boulevard, Rockville, MD
20850.
Contact Person: Lyle Furr, Contract Review
Specialist, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
VerDate Nov<24>2008
16:35 Mar 10, 2010
Jkt 220001
DHHS, Room 220, MSC 8401, 6101 Executive
Boulevard, Bethesda, MD 20892–8401, (301)
435–1439, 1f33c.nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel Clinical
Worlds: Enhancing Substance Abuse
Provider Training Through Emerging
Technologies (5544).
Date: April 27, 2010.
Time: 9:30 a.m. to 12 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6101
Executive Boulevard, Rockville, MD 20852.
Contact Person: Lyle Furr, Contract Review
Specialist, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 220, MSC 8401, 6101 Executive
Boulevard, Bethesda, MD 20892–8401, (301)
435–1439, 1f33c.nih.gov.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel Drug
Scene Investigation Science (1138).
Date: April 28, 2010.
Time: 9:30 a.m. to 12 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6101
Executive Boulevard, Rockville, MD 20852.
Contact Person: Lyle Furr, Contract Review
Specialist, Office of Extramural Affairs,
National Institute on Drug Abuse, NIH,
DHHS, Room 220, MSC 8401, 6101 Executive
Boulevard, Bethesda, MD 20892–8401, (301)
435–1439, 1f33c.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.279, Drug Abuse and
Addiction Research Programs, National
Institutes of Health, HHS)
Dated: March 4, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–5171 Filed 3–10–10; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HOMELAND
SECURITY
Transportation Security Administration
Intent To Request Renewal From OMB
of One Current Public Collection of
Information: Aviation Security
Customer Satisfaction Performance
Measurement Passenger Survey
Transportation Security
Administration, DHS.
ACTION: 60 day notice.
AGENCY:
SUMMARY: The Transportation Security
Administration (TSA) invites public
comment on one currently approved
Information Collection Request (ICR),
OMB control number 1652–0013,
abstracted below, that we will submit to
the Office of Management and Budget
(OMB) for renewal and amendment in
compliance with the Paperwork
Reduction Act. The ICR describes the
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
nature of the information collection and
its expected burden. The collection
involves surveying travelers to measure
customer satisfaction of aviation
security in an effort to more efficiently
manage airport performance.
DATES: Send your comments by May 10,
2010.
ADDRESSES: Comments may be emailed
to TSAPRA@dhs.gov or delivered to the
TSA Paperwork Reduction Act (PRA)
Officer, Office of Information
Technology (OIT), TSA–40,
Transportation Security Administration,
601 South 12th Street, Arlington, VA
20598–6040.
FOR FURTHER INFORMATION CONTACT:
Joanna Johnson at the above address, or
by telephone (571) 227–3651.
SUPPLEMENTARY INFORMATION:
Comments Invited
In accordance with the Paperwork
Reduction Act of 1995 (44 U.S.C. 3501
et seq.), an agency may not conduct or
sponsor, and a person is not required to
respond to, a collection of information
unless it displays a valid OMB control
number. The ICR documentation is
available at https://www.reginfo.gov.
Therefore, in preparation for OMB
review and approval of the following
information collection, TSA is soliciting
comments to—
(1) Evaluate whether the proposed
information requirement is necessary for
the proper performance of the functions
of the agency, including whether the
information will have practical utility;
(2) Evaluate the accuracy of the
agency’s estimate of the burden;
(3) Enhance the quality, utility, and
clarity of the information to be
collected; and
(4) Minimize the burden of the
collection of information on those who
are to respond, including using
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology.
Information Collection Requirement
OMB Control Number 1652–0013;
Aviation Security Customer Satisfaction
Performance Measurement Passenger
Survey. TSA, with OMB’s approval, has
conducted surveys of passengers and
now seeks approval to continue this
effort. TSA plans to conduct passenger
surveys at airports nationwide. The
surveys will be administered using an
intercept methodology. The intercept
methodology uses TSA personnel who
are not in uniform to hand deliver paper
survey forms to passengers immediately
following the passenger’s experience
with the TSA’s checkpoint security
E:\FR\FM\11MRN1.SGM
11MRN1
Agencies
[Federal Register Volume 75, Number 47 (Thursday, March 11, 2010)]
[Notices]
[Page 11552]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-5171]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The contract proposals and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal in formation concerning individuals
associated with the contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of person al privacy.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel Clinical Coordinating Support for NIDA Center for
Clinical Trials Network (CCTN) (2221).
Date: April 6, 2010.
Time: 9 a.m. to 2 p.m.
Agenda: To review and evaluate contract proposals.
Place: Courtyard by Marriott Rockville, 2500 Research Boulevard,
Rockville, MD 20850.
Contact Person: Lyle Furr, Contract Review Specialist, Office of
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS,
Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892-
8401, (301) 435-1439, 1f33c.nih.gov.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel Clinical Worlds: Enhancing Substance Abuse Provider
Training Through Emerging Technologies (5544).
Date: April 27, 2010.
Time: 9:30 a.m. to 12 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, 6101 Executive Boulevard,
Rockville, MD 20852.
Contact Person: Lyle Furr, Contract Review Specialist, Office of
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS,
Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892-
8401, (301) 435-1439, 1f33c.nih.gov.
Name of Committee: National Institute on Drug Abuse Special
Emphasis Panel Drug Scene Investigation Science (1138).
Date: April 28, 2010.
Time: 9:30 a.m. to 12 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, 6101 Executive Boulevard,
Rockville, MD 20852.
Contact Person: Lyle Furr, Contract Review Specialist, Office of
Extramural Affairs, National Institute on Drug Abuse, NIH, DHHS,
Room 220, MSC 8401, 6101 Executive Boulevard, Bethesda, MD 20892-
8401, (301) 435-1439, 1f33c.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.279, Drug
Abuse and Addiction Research Programs, National Institutes of
Health, HHS)
Dated: March 4, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-5171 Filed 3-10-10; 8:45 am]
BILLING CODE 4140-01-M